355 related articles for article (PubMed ID: 33827674)
21. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
Elife; 2020 Sep; 9():. PubMed ID: 32902381
[TBL] [Abstract][Full Text] [Related]
22. Oncohistones: Hijacking the histone code.
Sahu V; Lu C
Annu Rev Cancer Biol; 2022 Apr; 6():293-312. PubMed ID: 36589281
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive structural analysis of mutant nucleosomes containing lysine to glutamine (KQ) substitutions in the H3 and H4 histone-fold domains.
Iwasaki W; Tachiwana H; Kawaguchi K; Shibata T; Kagawa W; Kurumizaka H
Biochemistry; 2011 Sep; 50(36):7822-32. PubMed ID: 21812398
[TBL] [Abstract][Full Text] [Related]
24. The expanding landscape of 'oncohistone' mutations in human cancers.
Nacev BA; Feng L; Bagert JD; Lemiesz AE; Gao J; Soshnev AA; Kundra R; Schultz N; Muir TW; Allis CD
Nature; 2019 Mar; 567(7749):473-478. PubMed ID: 30894748
[TBL] [Abstract][Full Text] [Related]
25. Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
Chen CCL; Deshmukh S; Jessa S; Hadjadj D; Lisi V; Andrade AF; Faury D; Jawhar W; Dali R; Suzuki H; Pathania M; A D; Dubois F; Woodward E; Hébert S; Coutelier M; Karamchandani J; Albrecht S; Brandner S; De Jay N; Gayden T; Bajic A; Harutyunyan AS; Marchione DM; Mikael LG; Juretic N; Zeinieh M; Russo C; Maestro N; Bassenden AV; Hauser P; Virga J; Bognar L; Klekner A; Zapotocky M; Vicha A; Krskova L; Vanova K; Zamecnik J; Sumerauer D; Ekert PG; Ziegler DS; Ellezam B; Filbin MG; Blanchette M; Hansford JR; Khuong-Quang DA; Berghuis AM; Weil AG; Garcia BA; Garzia L; Mack SC; Beroukhim R; Ligon KL; Taylor MD; Bandopadhayay P; Kramm C; Pfister SM; Korshunov A; Sturm D; Jones DTW; Salomoni P; Kleinman CL; Jabado N
Cell; 2020 Dec; 183(6):1617-1633.e22. PubMed ID: 33259802
[TBL] [Abstract][Full Text] [Related]
26. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
Jain SU; Khazaei S; Marchione DM; Lundgren SM; Wang X; Weinberg DN; Deshmukh S; Juretic N; Lu C; Allis CD; Garcia BA; Jabado N; Lewis PW
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27354-27364. PubMed ID: 33067396
[TBL] [Abstract][Full Text] [Related]
27. H2B oncohistones cause homologous recombination defect and genomic instability through reducing H2B monoubiquitination in Schizosaccharomyces pombe.
Qin B; Lu G; Chen X; Zheng C; Lin H; Liu Q; Shang J; Feng G
J Biol Chem; 2024 May; 300(6):107345. PubMed ID: 38718864
[TBL] [Abstract][Full Text] [Related]
28. Histone H3.3 and cancer: A potential reader connection.
Lan F; Shi Y
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6814-9. PubMed ID: 25453099
[TBL] [Abstract][Full Text] [Related]
29. Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation.
Mitchener MM; Muir TW
Mol Cell; 2022 Aug; 82(16):2925-2938. PubMed ID: 35985302
[TBL] [Abstract][Full Text] [Related]
30. Surprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail.
Lowe BR; Yadav RK; Henry RA; Schreiner P; Matsuda A; Fernandez AG; Finkelstein D; Campbell M; Kallappagoudar S; Jablonowski CM; Andrews AJ; Hiraoka Y; Partridge JF
Elife; 2021 Feb; 10():. PubMed ID: 33522486
[TBL] [Abstract][Full Text] [Related]
31. Integrative Chemical Biology Approaches to Deciphering the Histone Code: A Problem-Driven Journey.
Li X; Li XD
Acc Chem Res; 2021 Oct; 54(19):3734-3747. PubMed ID: 34553920
[TBL] [Abstract][Full Text] [Related]
32. Histone H3G34 Mutation in Brain and Bone Tumors.
Qiu L; Han J
Adv Exp Med Biol; 2021; 1283():63-71. PubMed ID: 33155138
[TBL] [Abstract][Full Text] [Related]
33. Novel types and sites of histone modifications emerge as players in the transcriptional regulation contest.
Kebede AF; Schneider R; Daujat S
FEBS J; 2015 May; 282(9):1658-74. PubMed ID: 25220185
[TBL] [Abstract][Full Text] [Related]
34. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.
Jayaram H; Hoelper D; Jain SU; Cantone N; Lundgren SM; Poy F; Allis CD; Cummings R; Bellon S; Lewis PW
Proc Natl Acad Sci U S A; 2016 May; 113(22):6182-7. PubMed ID: 27185940
[TBL] [Abstract][Full Text] [Related]
35. Genes of the month: H3.3 histone genes: H3F3A and H3F3B.
Kumar VC; Pai R
J Clin Pathol; 2021 Dec; 74(12):753-758. PubMed ID: 34667098
[TBL] [Abstract][Full Text] [Related]
36. A lesson learned from the H3.3K27M mutation found in pediatric glioma: a new approach to the study of the function of histone modifications in vivo?
Chan KM; Han J; Fang D; Gan H; Zhang Z
Cell Cycle; 2013 Aug; 12(16):2546-52. PubMed ID: 23907119
[TBL] [Abstract][Full Text] [Related]
37. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
[TBL] [Abstract][Full Text] [Related]
38. Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Shi L; Shi J; Shi X; Li W; Wen H
J Mol Biol; 2018 May; 430(11):1562-1565. PubMed ID: 29689253
[TBL] [Abstract][Full Text] [Related]
39. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
40. A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.
Bennett RL; Bele A; Small EC; Will CM; Nabet B; Oyer JA; Huang X; Ghosh RP; Grzybowski AT; Yu T; Zhang Q; Riva A; Lele TP; Schatz GC; Kelleher NL; Ruthenburg AJ; Liphardt J; Licht JD
Cancer Discov; 2019 Oct; 9(10):1438-1451. PubMed ID: 31337617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
